A Selective Culture Medium for Screening Cefiderocol Resistance in <i>Enterobacterales</i> , Pseudomonas aeruginosa, and Acinetobacter baumannii-Reference-Cited by-同舟云学术

A Selective Culture Medium for Screening Cefiderocol Resistance in Enterobacterales , Pseudomonas aeruginosa, and Acinetobacter baumannii

Published:2023-07-20 Issue:7 Volume:61 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Ibrahim Ahmad¹²³^ORCID,Bouvier Maxime⁴,Sadek Mustafa⁴⁵^ORCID,Decousser Jean-Winoc⁶⁷⁸^ORCID,Poirel Laurent²⁴³^ORCID,Nordmann Patrice²⁴³^ORCID

Affiliation:

1. Clinical Microbiology Unit, Pasteur Institute of Lille, Lille, France

2. European Institute for Emerging Antibiotic Resistance, Pasteur Institute, Lille, France

3. European Institute for Emerging Antibiotic Resistance, University of Fribourg, Fribourg, Switzerland

4. Medical and Molecular Microbiology, University of Fribourg, Fribourg, Switzerland

5. Department of Food Hygiene and Control, Faculty of Veterinary Medicine, South Valley University, Qena, Egypt

6. Equipe Opérationnelle d’Hygiène, Département Prévention, Diagnostic, Traitement des Infections, Hôpitaux Universitaires Henri-Mondor AP-HP, Créteil, France

7. DYNAMYC, University Paris Est Creteil, Créteil, France

8. DYNAMYC, EnvA, Maisons-Alfort, France

Abstract

Cefiderocol (FDC) is a siderophore cephalosporin with a broad spectrum of activity against many multidrug-resistant Gram-negative bacteria. Acquired resistance to FDC has been already reported among Gram-negative isolates, thus highlighting the need for rapid and accurate identification of such resistant pathogens, in order to control their spread.

Funder

I-Site ULNE

Swiss National science foundation

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/jcm.01883-22

Reference30 articles.

1. In Vitro Activity of Cefiderocol Against a Broad Range of Clinically Important Gram-negative Bacteria

2. In Vitro Antibacterial Properties of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacteria

3. Cefiderocol: Systematic Review of Mechanisms of Resistance, Heteroresistance and In Vivo Emergence of Resistance

4. Role of AxyABM overexpression in acquired resistance in Achromobacter xylosoxidans

5. In Vitro Activity and In Vivo Efficacy of Cefiderocol against Stenotrophomonas maltophilia